Mutational screening of the EPHB2 gene in 116 patients with familial colorectal cancer identified 3 novel missense nucleotide changes and the D679N variant previously suggested by Huusko et al.[11] to be pathogenic in prostate cancer (Table 1). This evidence concerns the gene EPHB2 and prostate carcinoma.